Is Novavax Stock Still a Buy With Its Management’s Credibility Crumbling?

There are lots of mistakes that corporate executives can make. One of the most problematic is overpromising and underdelivering. This blunder can lead to an erosion of credibility. Novavax(NASDAQ:NVAX) CEO Stan Erck and his leadership team face this very…

Click here to view the original article.